Song Esther sold $45K of SYNA

Song Esther (See Remarks) sold 437 shares of SYNAPTICS Inc (SYNA) at an average of $103.68 ($102.73–$104.78) across 3 trades on 2026-08-18 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Song Esther
Published Aug 19, 2026, 10:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 10:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SYNA
Neutral
high confidence
Mentioned
$SYNA
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SYNANeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to move the stock, but it adds to the cumulative insider activity record.

02

Market read

Routine insider sell with minimal trading relevance; useful for monitoring insider trends.

03

What to watch

Potential upcoming product announcements or earnings that may offset the sell pressure.

Relevance 2/10Novelty 4/10Timing: filed after market close on 2026-08-19

Background

Form 4 filings disclose insider transactions; a 10b5-1 plan indicates pre‑arranged sales, often unrelated to material news.

Company-level read

Ticker impact

$SYNANeutralHigh confidence
Context

Officer sold 437 shares for $45,307 via a 10b5-1 plan, reducing holdings to 14,683 shares.

Expected impact

No significant move expected; slight downward pressure possible.

Evidence & confidence

The sale amount is small relative to float and disclosed under a pre-arranged plan, indicating no urgent information.

Market effects

None; Synaptics operates in the broader semiconductor/technology sector with no sector-wide impact.

No regional effect; the transaction is company‑specific.

Limited to investors tracking insider activity.

Counterpoint

The sale could be interpreted as a signal of insider concern, but the 10b5-1 plan suggests routine liquidity.

Key entities

  • Song Esther

    Insider reporting the sale.

  • Synaptics Inc

    Manufacturer of human interface solutions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SYNAMed

SYNA Q1 Earnings Beat Estimates, Revenues Miss on Weak Demand

Synaptics reported Q1 earnings of $1.26 per share, up 15.6% YoY, beating estimates, while revenue grew 0.5% to $294M, missing estimates. Weak demand and supply constraints impacted results. The company expanded its Edge AI portfolio and withheld guidance due to its pending acquisition by onsemi.

$SYNAMed

Synaptics Reports First Quarter Fiscal 2027 Results

SYNAPTICS Inc (SYNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Synaptics Reports First Quarter Fiscal 2027 Results Q1'27 Financial Results • Revenue of $294.0 million, up 1% year-over-year • GAAP gross margin of 47.8% • Non-GAAP gross margin of 54.3% • GAAP loss per share of $0.45 • Non-GAAP diluted earnings per share of $1.26 K

$SYNAHighAI 8/10

FPA Queens Road Small Cap Value Fund Reduces Its Stake in Synaptics (SYNA) Following Onsemi Acquisition Deal

FPA Queens Road Small Cap Value Fund reported a -7.62% Q3 2026 return, underperforming the Russell 2000 Value Index. The fund reduced its stake in Synaptics (SYNA) following its acquisition by Onsemi (ON) for $7B. SYNA's stock traded between $58.28 and $149.11 over 52 weeks, closing at $117.86 on October 30, 2026. The fund cited SYNA's legacy in chip design and its Astra IoT/AI solution as key factors.

$SYNAHighAI 9/10

Onsemi Cuts Synaptics Buyout Price to $5.7 Billion After Rival Bid

Onsemi revised its acquisition of Synaptics, offering $123 per share in cash, reducing the deal's value from $7B to $5.7B. The change followed a rival bid from Cirrus Logic, which later withdrew. Onsemi's shares rose 6%, and Synaptics gained 14%. The deal requires shareholder and regulatory approval, with a expected close by mid-2027.